Farallon Capital Management »

Strategy Inc Note 3/0 shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Strategy Inc Note 3/0 shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Strategy Inc Note 3/0

Tip: Access up to 7 years of quarterly data

All positions including Strategy Inc Note 3/0 held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Strategy Inc Note 3/0 by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 2.6M 0.88

More positions owned by Farallon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Electronic Arts (EA)
Bridgebio Pharma (BBIO)
Protagonist Therapeutics (PTGX)
Exelixis (EXEL)
Liquidia Corporation Com New (LQDA)
Amazon (AMZN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Natera (NTRA)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Roivant Sciences SHS (ROIV)
Aon Shs Cl A (AON)
Boston Scientific Corporation (BSX)

View all positions for Farallon Capital Management

Top funds holding Strategy Inc Note 3/0

D. E. Shaw & Co
Linden Advisors
Aristeia Capital
Balyasny Asset Management
Millennium Management
Weiss Asset Management LP[1
LMR Partners
Wolverine Asset Management
Walleye Trading Advisors
Whitebox Advisors
Two Sigma Investments
State Street Corporation
BlackRock
Context Capital Management
FMR

View all funds holding Strategy Inc Note 3/0